Revisiting fibrosis in inflammatory bowel disease: the gut thickens | Nature Reviews Gastroenterology & Hepatology
Fresenius Kabi receives U.S. FDA approval for biosimilar Idacio® (adalimumab) - Fresenius Kabi Global
Fresenius Kabi UK Events (@FreseniusKabiGB) / Twitter
Nutrients | Free Full-Text | The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management
Fresenius starts $250M U.S. site expansion | Fierce Pharma
CDHF Talks: Dietary Updates and Recommendations for the IBD Patient on a Biosimilar - Canadian Digestive Health Foundation
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases - The Lancet Gastroenterology & Hepatology
Fresenius Kabi recalls Ivenix Infusion System over leaks that delay, interrupt therapy
Fresenius Kabi Chips Away at Neulasta Market in Germany
Fresenius Kabi - Canadian Digestive Health Foundation
JCM | Free Full-Text | Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge
PROJECT
Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative Colitis | MedPage Today
Review article: randomised controlled trials in inflammatory bowel disease—common challenges and potential solutions - Schreiber - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Fresenius Kabi wants Wockhardt to change "wrong" BSE filing
Fresenius Kabi - Visit the Fresenius Kabi booth at the ECCO Virtual Congress 2021 from July 8 – 10 and learn more about biosimilars, our commitment to helping more patients access biologics,
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG‐ IBD study - Dragoni - United European Gastroenterology Journal - Wiley
Microbiota, Nutrition and Inflammation: An opening towards personalized IBD treatment
Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
Fresenius Kabi secures US FDA approval for its adalimumab biosimilar
Fresenius Kabi recalls newly acquired infusion pump system
Diagnosis, Management, and Monitoring of IBD: Early Diagnosis and Individualizing Therapy | CCO
Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management? - ScienceDirect
Low Risk for IBD Relapse After Switch From IV to Subcutaneous Infliximab | MedPage Today
Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition - ScienceDirect
Investor News | FSE
